Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H16O7 |
Molecular Weight | 272.2512 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@@H](OC2=CC=C(O)C=C2)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=BJRNKVDFDLYUGJ-RMPHRYRLSA-N
InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12-/m1/s1
Molecular Formula | C12H16O7 |
Molecular Weight | 272.2512 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:20:32 UTC 2023
by
admin
on
Fri Dec 15 15:20:32 UTC 2023
|
Record UNII |
C5INA23HXF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
||
|
DSLD |
1289 (Number of products:3)
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11217
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
m2033
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | Merck Index | ||
|
207-850-3
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
7661
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
C5INA23HXF
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
497-76-7
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
SUB33412
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
C5INA23HXF
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
C87429
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
DTXSID7040152
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
18305
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
4267
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
100000126183
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
1367175
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | RxNorm | ||
|
4036
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
440936
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY | |||
|
ARBUTIN
Created by
admin on Fri Dec 15 15:20:32 UTC 2023 , Edited by admin on Fri Dec 15 15:20:32 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ASSAY (HPLC)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
Unit: mg (calculated as arbutin); Urinary elimination profiles of arbutin metabolites (150mg arbutin in about 150mL aqueous bearberry leaf extract oral q.i.d., n=3, 16-24hr urine)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Unit: mg (calculated as arbutin); 150mg arbutin in about 150mL aqueous bearberry leaf extract, q.i.d.; 0-24hr urine; n=3
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Amount excreted in urine within the 36-hour study period, 945mg bearberry leaf extract (corresponding to 210mg arbutin, in two film coated tabs) single oral administration, n=16 (8 female, 8 male), 0-36hr urine
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Amount excreted in urine within the 36-hour period, 945mg bearberry leaf dry extract (210mg arbutin equivalent, in aqueous solution) single oral administration, n=16 (8 female, 8 male)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Unit: mg; Amount excreted in urine within 36-hr study period, Bearberry leaves dry extract(BLDE) 945mg single oral administration(210mg arbutin correspondence, in 2 film coated tabs, each contained 472.5mg BLDE or 105mg arbutin), n=16 (8 female & 8 male)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
945mg bear berry leaf extract (w/210mg arbutin) single oral administration, 0-4hr urine, n=1
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Unit: mg; Amount excreted in urine within 36-hr study period, Bearberry leaves dry extract(BLDE) 945mg single oral administration(210mg arbutin correspondence, aqueous solution), n=16 (8 female & 8 male)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Amount excreted in urine within the 36-hour period, 945mg bearberry leaf dry extract (210mg arbutin equivalent, in two film coated tabs) single oral administration, n=16 (8 female, 8 male)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
Unit: mg calculated as arbutin; Urinary elimination of arbutin metabolites (16-24hr urine, n=3, 150mg arubutin in about 150mL aqueous bearberry leaf extract, q.i.d.)
IN-VIVO
URINE
|
||
|
METABOLITE -> PARENT |
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |